Penn Blood Disorder Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Penn Blood Disorder Center has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Hemophilia B, Hemophilia A.
Sponsors: Pfizer.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Penn Blood Disorder Center has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Penn Blood Disorder Center has 2 clinical trials on record, with 1 currently active. Their work covers Hemophilia B, Hemophilia A.
Penn Blood Disorder Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.